General Archive
-
BlogsLearning to live with a bronchiectasis diagnosis – Gaynor’s story
Grandmother of 4, Gaynor Hardman, was diagnosed with bronchiectasis at 61. With limited knowledge and understanding of this condition, she…
-
News releasesDr Sam Barrell CBE joins LifeArc as new CEO
We are excited to welcome Dr Sam Barrell, CBE, as she officially joins the LifeArc team today as our new…
-
ArticlesBronchiectasis: an overlooked lung condition with untapped commercial and research potential
Bronchiectasis (BE) is a chronic lung condition that significantly impacts the lives of many people in the UK and around…
-
News releasesResearch shows potential ‘life-transforming’ mole reversal therapy in rare condition
Researchers at the Francis Crick Institute, UCL Great Ormond Street Institute for Child Health and Great Ormond Street Hospital for…
-
ArticlesThe new LifeArc identity: More than just a fresh coat of paint
In the world of medical research, it’s vital that we keep challenging ourselves to push forwards. We’ve created a new…
-
News releasesNew partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development
LifeArc and ALS Therapy Development Institute (ALS TDI) have joined forces to identify, validate, and develop new biomarkers that are…
-
ArticlesLifeArc Translational Science Summit: Highlights and key takeaways
The first ever LifeArc Translational Science Summit was a resounding success! Held on 23 April in London, the event brought…
-
News releasesFirst-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Great Ormond Street Hospital (GOSH), supported by LifeArc and Great Ormond Street Hospital Children’s Charity (GOSH Charity), is announcing its…
-
News releasesLifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership
The Crick Africa Network (CAN), a partnership between LifeArc, the Francis Crick Institute and 5 African institutions, has now awarded…
-
News releasesLifeArc funds pivotal clinical trial to treat an ultra-rare genetic disease with possible link to leader of the mutiny on the Bounty in 1789
A pivotal clinical trial to look at repurposing the UK-licensed medicine, deferiprone, for patients with neuroferritinopathy, an ultra-rare genetic disease…
-
News releasesReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya
ReAct (Action on Antibiotic Resistance) Africa, in partnership with self-funded medical research organisation and charity LifeArc, is excited to introduce…
-
Articles6 challenges in rare disease research and how we can overcome them
Rare conditions, individually, have low patient numbers. However, with more than 7,000 rare diseases identified, collectively there are millions of…